BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25148409)

  • 1. Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
    Zeng Y; Zheng YQ; Wang L
    J Cosmet Laser Ther; 2014 Dec; 16(6):311-3. PubMed ID: 25148409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
    Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod: a review of its use in genital warts.
    Perry CM; Lamb HM
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imiquimod in the treatment of recalcitrant warts: a new therapy option?].
    Hesterberg U; Böhlen LM; Brand CU
    Praxis (Bern 1994); 2003 Mar; 92(12):535-9. PubMed ID: 12693144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod in the treatment of cutaneous warts: an evidence-based review.
    Ahn CS; Huang WW
    Am J Clin Dermatol; 2014 Oct; 15(5):387-99. PubMed ID: 25186654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
    Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
    Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional Laser-Assisted Topical Imiquimod 5% Cream Treatment for Recalcitrant Common Warts in Children: A Pilot Study.
    Park SM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    Dermatol Surg; 2016 Dec; 42(12):1340-1346. PubMed ID: 27598444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
    Harwood CA; Perrett CM; Brown VL; Leigh IM; McGregor JM; Proby CM
    Br J Dermatol; 2005 Jan; 152(1):122-9. PubMed ID: 15656812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
    Diamantis ML; Bartlett BL; Tyring SK
    Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
    J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical imiquimod for recalcitrant facial flat warts.
    Schwab RA; Elston DM
    Cutis; 2000 Mar; 65(3):160-2. PubMed ID: 10738635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities.
    Grussendorf-Conen EI; Jacobs S; Rübben A; Dethlefsen U
    Dermatology; 2002; 205(2):139-45. PubMed ID: 12218229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
    Miranda-Verástegui C; Llanos-Cuentas A; Arévalo I; Ward BJ; Matlashewski G
    Clin Infect Dis; 2005 May; 40(10):1395-403. PubMed ID: 15844060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
    Senatori R; Dionisi B; Lippa P; Inghirami P
    Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod in clinical practice.
    Edwards L
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
    Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
    J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five cases of recalcitrant plantar warts successfully treated with imiquimod 5% cream.
    López-Giménez MT
    Actas Dermosifiliogr; 2013 Sep; 104(7):640-2. PubMed ID: 23870849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.